Lantheus Medical Imaging has signed a new agreement under which it will receive molybdenum-99 (Mo-99) from the reopened Chalk River reactor. The company will receive a weekly supply of Mo-99 from the facility, which is expected to resume production at the end of this month. Mo-99 is ...
Please Login to read the full article.
